TIRZEPATIDE 30MG
Tirzepatide is a next-generation peptide developed as a dual receptor agonist, activating both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) pathways. This dual incretin activity is the focus of research into blood sugar regulation, weight loss mechanisms, and metabolic balance. With higher-strength formulations such as this 30mg option, Tirzepatide is of interest for studies requiring extended dosing potential.
Hotline Order:
Mon - Fri: 07AM - 06PM
(+965) 7492-4277
Tirzepatide 30mg
Tirzepatide is a next-generation peptide developed as a dual receptor agonist, activating both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) pathways. This dual incretin activity is the focus of research into blood sugar regulation, weight loss mechanisms, and metabolic balance. With higher-strength formulations such as this 30mg option, Tirzepatide is of interest for studies requiring extended dosing potential.
Research Highlights
Studied for glucose metabolism, appetite suppression, and satiety response.
Researched for insulin sensitivity, fat metabolism, and energy regulation.
Explored for roles in weight management, cardiovascular support, and lipid health.
Why Choose Tirzepatide from GeoPeptides?
- ≥99% purity, laboratory verified
- Dual-pathway incretin research compound
- Manufactured in the USA
- Fast, discreet worldwide shipping
Product Details
- Compound: Tirzepatide
- Strength: 30mg lyophilized peptide
- CAS: 2023788-19-2
- Molecular Formula: C225H348N48O68
- Molecular Weight: 4813.55 g/mol
- Appearance: Clear
- Form: Single vial
